
Web Release Date: April 15,
Relation of Time of Introduction of Cow Milk Protein to an Infant and Risk of Type-1 Diabetes Mellitus
Anatek-EP, P.O. Box 3677 Portland, Maine 04104
Received January 18, 2008
Abstract:
Several studies of infant feeding show a causal relationship between time of introduction of formula containing cow protein and risk of onset of type-1 diabetes mellitus. This paper cites the literature pro and con and discusses lipocalins which might play a role in the pathogensis. β Lactoglobulin, a major lipocalin protein in bovine milk, is homologous to the human protein glycodelin (PP14), a T cell modulator. Anti-β lactoglobulin cross-reacts with glycodelin. The newborn intestine does not have complete “closure” and can pass food antigens. β Lactoglobulin could generate antibody to glycodelin undermining T cell regulation of beta cells.
The intent of this communication is to review the relationship between lipocalins β lactoglobulin, a major whey protein of bovine milk, and a human protein of pregnancy, glycodelin (PP14), an immunomodulator, and the possible negative effect on insulin producing beta cells. Lipocalins are known allergens,1 and β lactoglobulin has been identified as a cow’s milk allergen. 2, 3 Bovine milk plays a large role in the human diet, particularly with young children. If a newborn is not breastfed, formula, a modification of cow’s milk, is the sole source of nutrition. The possibility of antigenic cross reactivity with the protein glycodelin which could influence autoimmune activity needs to be investigated. Type-1 diabetes mellitus is an autoimmune disease.
The literature is equivocal about the relationship of cow milk products, particularly the relationship between time of introduction to an infant and the onset of type-1 diabetes mellitus. A large controlled case study in Finland4 concluded that the age of introduction of dairy products is associated with risk of type-1 diabetes mellitus. A review paper “Milk and Diabetes”5 lists several studies which suggest cow milk products are associated with the onset of type-1 diabetes and several other studies which show no correlation. In addition, the work of Fort et al.6 and Wasmuth et al.7 does not support the conclusion, while Cavallo et al.,8 Saukkonen et al.,9 and, recently, Rosenbauer et al.10 do. These studies involve analysis of exclusive breastfeeding and time of introduction of formula. The supporting studies found introduction of formula before 4 months of age had a significant relationship with disease onset.
The Finland case study (matched samples and controlled for multiple factors)4 looked at 690 type-1 diabetes mellitus children <14 years, diagnosed between September 1986 and April 1989. The study was set up to distinguish between effect of duration of breast feeding and time of introduction of dairy products. The study found increased risk with early introduction of dairy products. The study cites Savilahti et al.11 who found increased levels of IgA and IgG antibody to β lactoglobulin in newly diagnosed diabetic children compared with nondiabetic. Virtanen et al. later confirmed patients <3 years had markedly higher IgG and IgA to cow milk and IgG antibodies to β lactoglobulin.12 IgA antibodies to β lactoglobulin were shown to associate with risk for type-1 diabetes.13
Lipocalins are a large group of small extracellular proteins with diversity at the sequence level, but highly conserved crystal structures.14 They have the ability to bind a range of small hydrophobic molecules.15 A subset, α1acid glycoprotein, α1microglobulin. and glycodelin, which exert significant immunomodulatory effects in vitro has been termed immunocalins.16 Glycodelin has three well-defined isoforms,17 glycodelin-A, glycodelin-S, and glycodelin-F. All have the same protein sequence, but different carbohydrate moieties. This suggests the glycans mediate the biological actions.18 Glycodelin-A, synthesized in the endometrium, is abundant in amniotic fluid. Glycodelin-S is abundant in seminal plasma. Glycodelin-F is found in follicular fluid.19
β Lactoglobulin is present in the milk of ruminants, but not humans.20 It has the largest concentration of any whey protein in bovine milk, 3 g/L. A 1986 paper in Nature21 suggested the structure was similar to plasma retinol-binding protein, and its function might be vitamin A transport. It has an unusual protein fold composed of two slabs of antiparallel β sheets. A reversible change can occur aound pH 7.0 known as the Tanford transition causing a change in conformation.22 The function of the protein has never been confirmed, but it is known to bind many hydrophobic ligands. The common genetic variants are A and B. Cows are described as phenotype A/A, B/B, or A/B.23 Isoform A shows a slightly lower molecular size on SDS-PAGE.2 β Lactoglobulin exists as a monomer–dimer mixture in solution moderated by pH and salt concentration.24 At its pI 5.2, it is a stable dimer of 34 kDa. Between pH 3.4 and 5.2, dimers of both variants associate to form octamers with association stronger with β lactoglobulin A. Antibody raised to either variant recognizes both, but β lactoglobulin A generated a greater antibody response.2
Glycodelin has significant homology with β lactoglobulin.25, 26 It is a major soluable protein of pregnancy and is known to directly modulate T cells.27, 28 It is a 28 kDa glycoprotein particularly expressed in steroid-responsive tissues of the female reproductive tract; the endometrium in response to progesterone. There is a large concentration in amnionic fluid which is thought to be a nutritive protein for the fetus in early pregnancy.29 It is a negative regulator in T cell receptor-mediated activation.30 Foth et al.31 show that endometrium and ovary are not the only source of the protein, and Morrow et al.32 identify a hematopoietic glycodelin (PP14) with anti-PP14 antibody. Antibody raised to β lactoglobulin cross-reacts with glycodelin.33
Milk is species-specific. Between 2 and 3% of children under 2 years have cow’s milk allergy, an IgE moderated disease.3 It is speculated that most adults have some IgG antibodies to cow milk proteins which do not appear to cause any ill effects. Researchers34 have looked at IgG and IgM antibody to cow’s milk proteins in sera of type-1 diabetes mellitus individuals. IgG levels to casein were higher in type-1 diabetes children, but not significant. Also, serum IgG to bovine insulin was investigated.35 Neither study identified antibody with a relationship to pathogenesis.
In our laboratory, we looked at 5 sera from individuals between 20 and 30 years, 2 males and 3 females, using immunoblots of 2D separations of cow’s milk. All 5 had antibody to kappa casein, 4 had antibody to As1 and β casein, 3 to butyrophilin, 2 to albumin, 1 to α lactalbumin; β lactoglobulin had 1 positive to the 34 kDa dimer and 17 kDa monomer doublet, and 1 positive just to the 17 kDa monomer doublet.
We looked at 5 sera from juveniles with type-1 diabetes: males 7, 10, and 13 years, and 2 females 14 years. Four had antibody to As1, As2, β and kappa casein. Four had antibody to butyrophilin, 3 to albumin, and 3 to α lactalbumin. All 5 had antibody to β lactoglobulin 34 kDa dimer, 17 kDa monomer doublet, and 16 kDa monomer doublet. None of the nondiabetic sera had antibody to the 16 kDa doublet. All β lactoglobulin spots were confirmed with A′β lactoglobulin antisera and by MS. β Lactoglobulin isoform A has a slightly lower molecular size. This suggests that the 16 kDa doublet is the A isoform. All type-1 positive sera had antibody to β lactoglobulin doublet spots at 16 kDa. None of the nondiabetic sera showed antibody to these 2 spots. Blast25 did not identify any β lactoglobulin homology with islet-cell proteins, but significant homology to glycodelin.
Intestinal “closure” in humans (the loss of ability of the intestinal membrane to take up macromolecules) is thought to take place during the seventh–eighth month of fetal gestation.36 However, Walker et al.37 have shown that food antigens can still pass easily through neonatal intestine, and β lactoglobulin may generate antibody to glycodelin.
A complex situation may involve β lactoglobulin antibody eliminating glycodelin and allowing proliferation of autoreactive T cells. The immature immunogenotype of some infants may see the 16 kDa β lactoglobulin as foreign and produce antibody which cross-reacts with glycodelin. Type-1 diabetes mellitus is thought to be caused by autoimmune destruction of pancreatic β cells by T cells.38 Destruction of glycodelin, a negative regulator, may allow proliferation of these cells. This intricate set of conditions may be the reason research to this point has not found a clear answer to the relationship of cow milk products and type 1-diabetes mellitus.
* Address correspondence to Marcia F. Goldfarb, Anatek-EP, P.O. Box 3677, Portland, ME 04104; tel, 207 883 0770 ; fax, 207 772 5644; e-mail, anatekep@maine.rr.com.
1. Virtanen, T.; Zeiler, T.; Mantyjarvi, R. Important animal allergens are lipocalin proteins: why are they allergenic. Int. Arch. Allergy Immunol. 1999, 4, 247–258.
2. Malik, Z.; Bottomley, R.; Austen, B. Allergenic properties of the genetic variants A and B of bovine beta-lactoglobulin. Int. Arch. Allergy Appl. Immunol. 1988, 86, 245–248.
3. Natale, M.; Bisson, C.; Monti, G.; Petran, A.; Garoffo, L. P.; Valentini, S.; Fabris, C.; Bertino, E.; Coscia, A.; Conti, A. Cow’s milk allergens identification by two-dimensional immunoblotting and mass spectrometry. Mol. Nutr. Food Res. 2004, 5, 363–369.
4. Virtanen, S. M.; Rasanen, L.; Ylonen, K.; Aro, A.; Clayton, D.; Langholz, B.; Pitkaniemi, J.; Savilahti, E.; Lounmaa, R.; Tuomilehto, J.; Akerblom, H. K. The childhood in diabetes in Finland study group. Diabetes 1993, 42, 1786–1790.
5. Schrezenmeir, J.; Jagla, A Milk and diabetes. J. Am. Coll. Nutr. 2000, 19, 176S–190S.
6. Fort, P.; Lanes, R.; Dahlem, S.; Recker, B.; Weyman-Daum, M.; Pugliese, M.; Lifshitz, F. Breast feeding and insulin-dependent diabetes mellitus in children. J.Am. Coll. Nutr. 1986, 5, 439–441.
7. Wasmuth, H. E.; Kolb, H. Cow’s milk and immune mediated diabetes. Proc. Nutr. Soc. 2000, 59, 573–579.
8. Cavallo, M.; Fava, D.; Monetini, L.; Barone, F.; Pozzilli, P. Cell-mediated immune response to beta casein in recent-onset insulin-dependent diabetes: implications for disease pathogenesis. Lancet 1996, 348, 926–928.
9. Saukkonen, T.; Savilahti, E.; Madacsy, L.; Arato, A.; Korner, A.; Barkai, L.; Sarnesto, A.; Akerblom, H. K. Increased frequency of IgM antibodies to cow’s milk proteins in Hungarian children with newly diagnosed insulin-dependent diabetes mellitus. Eur. J. Pediatr. 1996, 155, 885–889.
10. Rosenbauer, J.; Herzig, P.; Giani, G. Early nutrition and risk of type 1 diabetes mellitus
a nationwide case-control study in preschool children. Exp. Clin. Endocrinol. Diabetes 2007, 8, 502–508.
11. Savilahti, E.; Akerblom, H. K.; Tainio, V-M.; Koskimies, S. Children with newly diagnosed insulin dependent diabetes mellitus have increased levels of cow’s milk antibodies. Diabetes Res. 1988, 7, 137–140.
12. Savilahti, E.; Saukkonen, T. T.; Virtala, E. T.; Tuomilehto, J.; Akerblom, H. K. The childhood diabetes in Finland study group. Increased levels of cow’s milk and β lactoglobulin antibodies in young children with newly diagnosed IDDM. Diabetes Care 1993, 16, 984–989.
13. Dahlquist, G.; Savilahti, E.; Landin-Olsson, M. An increased level of antibodies to betalactoglobulin is a risk determinant for early-onset type 1 (insulin dependent) diabetes mellitus independent of islet cell antibodies and early introduction of cow’s milk. Diabetologia 1992, 35, 980–984.
14. Koistinen, H.; Koistinen, R.; Seppala, M.; Burova, T. V.; Choiset, Y.; Haertle, T. Glycodelin and beta-lactoglobulin, lipocalins with a high structural similarity differ in ligand binding properties. FEBS Lett. 1999, 450, 158–162.
15. Flower, D. R. The lipocalin protein family: structure and function. Biochem. J. 1996, 318, 1–14.
16. Lodgberg, L.; Wester, L. Immunocalins: a lipocalin subfamily that modulates immune and inflammatory responses. Biochim. Biophys. Acta 2000, 1482, 284–297.
17. Yeung, W. S.; Lee, K. F.; Koistinen, R.; Koistinen, H.; Seppala, M.; Ho, P. C.; Chiu, P. C. Glycodelin: a molecule with multi-functions on spermatozoa. Soc. Reprod. Fertil. Suppl. 2007, 63, 143–151.
18. Seppala, M.; Koistinen, H.; Koistinen, R.; Chiu, P. C.; Yeung, W. S. Glyco-sylation related actions of glycodelin: gamete, cumulus cell, immune cell and clinical associations. Hum. Reprod. Update 2007, 3, 275–287.
19. Yeungs, W. S.; Lee, K. F.; Koistinen, R.; Koistinen, H.; Seppala, M.; Ho, P. C.; Chiu, P. C. Roles of glycodelin in modulating sperm function. Mol. Cell. Endocrinol. 2006, 250, 149–156.
20. Conti, A.; Godovac-Zimmermann, J. Antibodies raised against bovine β lactglobulin react with beta 2-microglobulin. A possible antigenic region at beta-LG position 124–140. Biol. Chem. Hoppe−Seyler 1990, 371, 261–263.
21. Papiz, M. Z.; Sawyer, L.; Eliopoulos, E. E.; North, A. C. T.; Findlay, J. B. C.; Sivaprasadarao, R.; Jones, T. A.; Newcomer, M. E.; Kraulis, P. J. The structure of β-lactoglobulin and its similarity to plasma retinol-binding protein. Nature 1986, 324, 383–385.
22. Sakura, K.; Goto, Y. Dynamics and mechanism of the Tanford transition of bovine beta-lactoglobulin studied using heteronuclear NMR spectroscopy. J. Mol. Biol. 2006, 356, 483–496.
23. Martin, P.; Szymanowska, M.; Zwierzchowski, L.; Leroux, C. The impact of genetic polymorphisms on the protein composition of ruminant milks. Reprod. Nutr. Dev. 2002, 42, 433–459.
24. Sakurai, K.; Oobatake, M.; Goto, Y. Salt-dependent monomer-dimer equilibrium of bovine beta-lactoglobulin at pH 3. Protein Sci. 2001, 11, 2325–2335.
25. Altschul, S. F.; Thomas, L.; Madden, A. A.; Schaffer, J. Z.; Zheng, Z.; Webb, M.; Lipman, D. J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997, 25, 3389–3402.
26. VanCong, N.; Vaisse, C.; Gross, M. S.; Slim, R.; Milgrom, E.; Bernheim, A The human placental protein 14 (PP14) gene is localized on chromosome 9q34. Hum. Genet. 1991, 5, 515–518.
27. Rachmilewitz, J.; Riely, G. J.; Tykocinski, M. L. Placental protein 14 functions as a direct T-cell inhibitor. Cell Immunol. 1999, 191, 26–33.
28. Rachmilewitz, J.; Borovsky, Z; Riely, G. J.; Miller, R.; Tykocinski, M. L. Negative regulation of T cell activation by placental protein 14 is mediated by the tyrosine phosphatase receptor CD45. J. Biol. Chem. 2003, 16, 14059–14065.
29. Burton, G..J.; Watson, A. L.; Hempstock, J.; Skepper, J. N.; Jauniaux, E. Uterine glands provide histiotrophic nutrition for the human fetus during the first trimester of pregnancy. J. Clin. Endocrinol. Metab. 2002, 6, 2954–2959.
30. Yanov, E.; Borovsky, Z.; Mishan-Eisenberg, G.; Rachmilewitz, J. Placental protein 14 regulates selective B cell responses. Cell Immunol. 2003, 2, 156–163.
31. Foth, D.; Meisel, M.; Nawroth, F.; Straube, W.; Romer, T. IGFBP-1 and glycodelin serum levels before and after hysterectomy with and without bilateral oophorectomy in premenopausal women. Eur. J. Obstet. Gynecol. Reprod. Biol. 2001, 1, 55–61.
32. Morrow, D.; Xiong, N.; Getty, R. R.; Ratajczak, M. Z.; Morgan, D.; Seppala, M.; Rittinen, L.; Gewirtz, A. M.; Tyocinski, M. L. Hematopoietic protein immunosuppressive factor in cells of the megakaryocytic lineage. Am. J. Pathol. 1994, 145, 1485–1495.
33. Dutta, B.; Mukhopadhyay, D.; Roy, N; Das, G.; Karande, A. A. Cloning, expression, purification, and immunocharacterization of placental protein-14. Protein Expression Purif. 19983, 327–334.
34. Neyestani, T. R.; Djalali, M.; Pezeshki, M.; Siassi, F.; Eshraghian, M. R.; Rajab, A.; Keshavarz, A. Serum antibodies to the major proteins found in Cow’s milk of Iranian patients with Type 1 diabetes mellitus. Diabetes Nutr. Metab. 2004, 2, 76–83.
35. Neyestani, T. R.; Djalali, M.; Pezeshki, M.; Siassi, F.; Eshraghian, M. R.; Rajab, A.; Keshavarz, A. Serum levels to bovine insulin in type 1 diabetes mellitus. Indian J. Pediatr. 2003, 9, 701–705.
36. Bainter K. Intestinal Absorption of Macromolecules and Immune Transmission from Mother to Young; CRC Press: Boca Raton, FL, 1986; p 107.
37. Bousvaros, A.; Walker, W. A. Development and function of the intestinal mucosal barrier. In Ontogeny of the Immune System of the Gut; MacDonald, T. T., Ed.; CRC Press: Boston, MA, 1990; pp 1–21.
38. Setteze, D. V.; Leiter, E. H. Tracking autoimmune T cells in diabetes. J. Clin Invest. 2003, 112, 826–828.